Stilboestrol and vaginal clear-cell adenocarcinoma syndrome.
A vaginal clear-cell adenocarcinoma developed in a young woman who had been exposed in utero to maternal stilboestrol treatment. During 1940-71 in the UK some 7500 women were given stilboestrol during pregnancy. Thus more cases are likely to appear and clinicians caring for young women should be alert to this possibility.
D000230:Adenocarcinoma / Q000139:chemically induced*; D000328:Adult; D004054:Diethylstilbestrol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D014625:Vaginal Neoplasms / Q000139:chemically induced*
D004054:Diethylstilbestrol